Lifecore Biomedical, Inc.
Key Metrics
- Previous Close
- $6.39
- 52-Week Range
- $3.63 – $8.98
- Market Cap
- $242.60M
- P/E (TTM)
- —
- EPS (TTM)
- -1.27
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- 2.66
- Return on Equity
- —
- Return on Assets
- —
- Gross Margin
- 27.49%
- Operating Margin
- -6.20%
- Profit Margin
- -66.76%
- Current Ratio
- 3.84
- Debt/Equity
- —
- Total Debt
- $162.18M
- Free Cash Flow
- —
- Revenue Growth
- -18.60%
- Earnings Growth
- —
- Enterprise Value
- $432.87M
Market Snapshot
About
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in complex sterile injectable pharmaceutical products. The company provides services including formulation development, aseptic fill-finish manufacturing, and commercial production for pharmaceutical and biotechnology companies. Lifecore also produces sodium hyaluronate, a biomaterial used in ophthalmic, orthopedic, and other medical applications.